Last reviewed: June 20, 2026

Last updated: June 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide therapy has transformed weight management for millions, but determining your therapeutic dose is not a one-size-fits-all process. Clinical trials show that doses ranging from 1.7 mg to 2.4 mg weekly produce meaningful weight loss, yet individual response varies significantly based on genetics, metabolism, and health status. PlexusDx personalizes your semaglutide dosing strategy to help you reach sustainable results.

Understanding Semaglutide Therapeutic Dose Ranges

Semaglutide operates as a GLP-1 receptor agonist that signals fullness and reduces appetite at the brain level. The therapeutic dose window for weight management typically begins at lower initiation levels and gradually increases over weeks to minimize side effects and allow your body to adapt. Most patients find their therapeutic range between 1.0 mg and 2.4 mg weekly, though the exact dose that works best for you depends on your unique physiology and treatment goals.

Clinical evidence demonstrates that therapeutic semaglutide doses produce an average weight loss of 15% to 22% of body weight over 68 weeks when combined with lifestyle modifications. Your dose may need to go up as your body adapts, but PlexusDx pricing remains flat—you never pay the same monthly price at every dose level. This means you can focus on health improvements rather than budget concerns.

How Your Body Determines Your Therapeutic Dose

Your GLP-1 receptor sensitivity, determined partly by genetic variants like GLP1R rs6923761, influences how your body responds to semaglutide. Some individuals achieve appetite control at 1.0 mg weekly, while others require closer to 2.4 mg to reach their therapeutic threshold. PlexusDx Precision Peptide Genetic Test examines your GLP-1 pathway activation capacity, giving your clinician concrete data about your likely dose requirements before treatment begins.

Metabolism speed also shapes therapeutic dosing. The FTO rs9939609 variant influences how your body processes appetite signals and energy storage. Patients carrying certain genetic variants may need dose adjustments to reach therapeutic effect, while others stabilize at lower amounts. Understanding these biological factors prevents under-dosing, which leaves weight loss potential unrealized, and over-dosing, which increases side effect burden.

Reaching Therapeutic Semaglutide Dose Safely

PlexusDx structures semaglutide therapy with gradual dose escalation—typically starting at 0.25 mg weekly and increasing by 0.25 mg increments every four weeks until you reach your therapeutic dose. This titration schedule allows your digestive system to adjust and helps identify your optimal balance between appetite suppression and tolerability. Most patients reach therapeutic effect within 8 to 12 weeks, though timelines vary.

Your clinician monitors how you respond at each dose level by tracking weight loss, appetite changes, and side effect patterns. If you experience nausea or gastrointestinal symptoms, staying at your current dose for an additional week often resolves discomfort without slowing progress. Once you stabilize at your therapeutic dose, PlexusDx compounded semaglutide injections deliver consistent medication quality from licensed 503A pharmacies, supporting reliable treatment outcomes across all 50 states.

Personalization Beyond Standard Dosing Protocols

Standard dosing guidelines treat all patients similarly, but your therapeutic dose should reflect your unique genetic blueprint. The MC4R rs17782313 variant and GIPR rs1800437 variant both influence how effectively semaglutide suppresses your appetite and coordinates energy balance. PlexusDx maps 14 pathways and 49 peptides related to weight regulation, providing your clinician with 150+ genetic insights that inform precise dose recommendations tailored to your biology.

PlexusDx Precision Peptide Genetic Test ($99 add-on after your first treatment month) identifies your predispositions across appetite, metabolism, and satiety pathways. Patients who opt for genetic testing often achieve their therapeutic dose more efficiently because dosing recommendations align with their actual genetic risk profile rather than population averages. This personalized approach typically reduces trial-and-error dose adjustments and accelerates the timeline to sustainable weight loss.

Maintaining Your Therapeutic Dose Long-Term

Once you reach your therapeutic semaglutide dose, maintaining consistency matters more than continual increases. Many patients find that 1.7 mg to 2.0 mg weekly sustains appetite suppression and weight loss indefinitely when paired with stable nutrition habits and physical activity. Your therapeutic dose represents the amount needed to keep your appetite-control system engaged at your target level—not necessarily the highest dose available.

PlexusDx supports long-term therapy with straightforward, flat monthly pricing whether you take 0.5 mg, 1.7 mg, or 2.4 mg weekly. HSA and FSA accounts cover compounded semaglutide injections, and no insurance or membership fees apply. Routine check-ins with your PlexusDx clinician confirm your dose remains optimal as your lifestyle and goals evolve, ensuring your therapeutic strategy adapts without unexpected cost increases.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is considered a therapeutic semaglutide dose for weight loss?

A therapeutic dose typically ranges from 1.0 mg to 2.4 mg injected weekly, with most patients finding appetite suppression and meaningful weight loss between 1.7 mg and 2.4 mg. Your specific therapeutic dose depends on your genetic response profile, metabolism, and health status. PlexusDx helps identify your optimal range through genetic testing and clinical monitoring.

How long does it take to reach a therapeutic dose of semaglutide?

Most patients reach therapeutic semaglutide dose within 8 to 12 weeks following standard titration protocols that increase the dose by 0.25 mg weekly. Your timeline may extend if you experience gastrointestinal adjustment or if your clinician slows increases to optimize tolerability. Genetic testing through PlexusDx can help predict your likely dose endpoint earlier in treatment.

Does PlexusDx charge more for higher semaglutide doses?

No. PlexusDx compounded semaglutide injections start at $149 per month with flat pricing across all dose levels—your dose may need to go up, but your price won't. All medications come from licensed 503A compounding pharmacies, work across all 50 states, and qualify for HSA and FSA coverage without membership fees.

What happens if my therapeutic semaglutide dose causes side effects?

Common side effects like nausea often resolve by maintaining your current dose for an extra week while your body adjusts. If side effects persist, your clinician may reduce your dose slightly to identify a therapeutic level you tolerate well—therapeutic benefit matters only if you can sustain treatment long-term. PlexusDx supports dose adjustments without penalty.

How does PlexusDx genetic testing improve my therapeutic dose?

PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R pathways that predict how your body responds to semaglutide. This $99 add-on after your first treatment month reveals your appetite-control predispositions across 14 pathways and 49 peptides, helping your clinician recommend a dose aligned with your actual biology rather than population averages—typically accelerating your path to therapeutic effect.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves